Loading the company…
Loading the company…
Families: Breast biopsy & localization, Bronchoscopy & lung nodule.
All companies · Product and company coverage
In the last ten years FDA made 4 decisions for Elucent Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2026 (1). The latest was on 2026-05-14.
| Family | Decisions on record |
|---|---|
| Breast biopsy & localization | 3 |
| Bronchoscopy & lung nodule | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-05-14 | 510(k) | K260565 | SmartClip Delivery Catheter (ADR-1715) |
| 2024-12-20 | 510(k) | K233639 | SmartClip Secure Soft Tissue Marker |
| 2019-03-22 | 510(k) | K183400 | EnVisio Navigation Sytem |
| 2018-06-04 | 510(k) | K180640 | SmartClip Soft Tissue Marker |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Elucent Medical.